Executive Board

Executive Board

Danjuma Adda

President

World Hepatitis Alliance

Gavin Cloherty

Director, Infectious Disease Research

Abbott Diagnostics

Chuck Cooper

Chief Medical Officer

Siemens Healthineers

Samir Desai

President & Head BU Biologics

Cadila Healthcare Limited (Zydus Cadila)

Matthew D'Uva

Chief Executive Officer

AASLD

Tommy Good

Senior International Product Manager, Hepatitis

Roche Diagnostics

Senior International Product Manager

Ben Hainsworth

Managing Director

EASL

Sherine Helmy

Chief Executive Officer

Pharco Pharmaceuticals

Patrick Knobel

Director, Therapeutic Area Strategies – Eye Care & Virology

International Government Affairs, AbbVie

Bruce Kreter

Executive Director

Global Liver Diseases Medical Affairs, Gilead Sciences

Lillian Lou

John C. Martin Foundation

Paul Schaper

Executive Director 

Global Pharmaceutical Public Policy, Merck Inc.

Ray Schinazi

Frances Winship Walters Professor of Pediatrics

Emory University, School of Medicine

Marcelo Silva

Head of Hepatology and Liver Transplant Unit

Austral University Hospital, President Latin American Association for the Study of the Liver

Sam So

Executive Director

Asian Liver Center, Stanford University

Carolyn Wester

Director of the Division of Viral Hepatitis

US Centers for Disease Control and Prevention

 

Last day updated 22 Aug 2023